comparemela.com
Home
Live Updates
CytomX Therapeutics Announces FDA Clearance of IND Applications for CX-2051, a Probody® ... : comparemela.com
CytomX Therapeutics Announces FDA Clearance of IND Applications for CX-2051, a Probody® ...
- Initiation of CX-2051 Phase 1 clinical study in EpCAM positive tumors including colorectal cancer anticipated in 1H 2024 -
Related Keywords
United States ,
Wayne Chu ,
Chris Ogden ,
Sean Mccarthy ,
Stephanie Ascher ,
Nasdaq ,
Drug Administration ,
Twitter ,
Bristol Myers Squibb ,
Amgen ,
Cytomx Therapeutics Inc ,
Linkedin ,
Investigational New Drug ,
Quarterly Report ,
Cytomx Therapeutics ,
Media Contact ,
Region ,
comparemela.com © 2020. All Rights Reserved.